|
July 2, 2012–FDA Approves Cornerstone Therapeutics’ ANDA for Generic Tussionex® Pennkinetic® Product. Coating Place Inc. (CPI) developed the active drug substances, Hydrocodone Polistirex and Chlorpheniramine Polistirex, using our Patented DRC Technology. These active drug substances will be manufactured at commercial scale in the CPI facilities. |
NEWS AND EVENTS
Coating Place, Inc. 200 Paoli Street | PO Box 930310 | Verona, WI 53593. Phone: (608) 845-9521 Fax: (608) 845-9526

